Viking Therapeutics Q1 Earnings Call Highlights [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
million (vs. $45.6M a year ago), while cash and short-term investments stood at $603 million , which management says should fund operations into through key catalysts. VK2735 clinical progress: The Phase 3 VANQUISH program is fully enrolled (~ in VANQUISH-1 and ~ in VANQUISH-2) and participants are being switched to an auto-injector; Viking plans to start oral VK2735 Phase 3 in Q4 2026 targeting no more than two tablets for higher doses. Maintenance study and new amylin program: The subcutaneous maintenance study was expanded from four to eight cohorts with subcutaneous results due in Q3 2026 (oral maintenance readouts in H1 next year), and Viking filed an IND for amylin agonist VK3019 with a Phase 1 program expected pending clearance. Interested in Viking Therapeutics, Inc.? Here are five stocks we like better. 3 Companies at the Forefront of the GLP-1 Pill Wars Viking Therapeutics (NASDAQ:VKTX) reported first-quarter 2026 financial results and outlined progress across its
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate UpdatePR Newswire
- What is Driving a Strong Bullish Sentiment Towards Viking Therapeutics (VKTX) [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (VKTX) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 4/29/26 - Miss
VKTX
Sec Filings
- 4/29/26 - Form 8-K
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- VKTX's page on the SEC website